Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.8 GBX | 0.00% | -6.91% | +41.44% |
May. 01 | Poolbeg Pharma Secures Full Patent in US for Immunomodulator II | MT |
May. 01 | Poolbeg Pharma celebrates full patent approval for Immunomodulator II | AN |
Evolution of the average Target Price on Poolbeg Pharma PLC
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- POLB Stock
- Consensus Poolbeg Pharma PLC